Piramal Pharma Ltd.

Research Piramal Pharma Ltd. (PPLPHARMA.NS) on Bullrun: market cap INR 262.00B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerPPLPHARMA.NS
ExchangeNSE
CountryIndia
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CurrencyINR
Market capINR 262.00B
Financial periodQ2 2026
RevenueINR 22.70B
Net income-INR 693.90M
Gross margin62.5%

Valuation Snapshot

latest market cap is INR 262.00B.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	INR 262.00B	n/a	n/a	0.14

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.14 INR.

About Piramal Pharma Ltd.

Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing;

Related stock research

India stocks India Healthcare stocks A-Z stock index

Other Healthcare stocks

Abbott India Ltd. (ABBOTINDIA.NS) Ajanta Pharmaceuticals Ltd. (AJANTPHARM.NS) Alkem Laboratories Ltd. (ALKEM.NS) Aurobindo Pharma Ltd. (AUROPHARMA.NS) Caplin Point Laboratories Ltd. (CAPLIPOINT.NS) Cipla Ltd. (CIPLA.NS) Cohance Lifesciences Ltd. (COHANCE.NS) Divi's Laboratories Ltd. (DIVISLAB.NS) Dr. Reddy's Laboratories Ltd. (DRREDDY.NS) Emcure Pharmaceuticals Ltd. (EMCURE.NS) Gland Pharma Ltd. (GLAND.NS) Glenmark Pharmaceuticals Ltd. (GLENMARK.NS)

Frequently asked questions

What is Piramal Pharma Ltd.'s market cap?

Piramal Pharma Ltd.'s market capitalization is INR 262.00B.